Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surface interactions between macrophages and Trypanosoma cruzi

S G Reed, T G Douglass, C A Speer

    The American Journal of Tropical Medicine and Hygiene
    |July 1, 1982
    PubMed
    Summary

    Immune macrophages and specific antibodies enhance Trypanosoma cruzi parasite binding and destruction. Immune responses are crucial for controlling T. cruzi infections by boosting macrophage activity against both epimastigote and trypomastigote forms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.

    Scandinavian journal of immunology·2017
    Same author

    Leishmania vaccine development: exploiting the host-vector-parasite interface.

    Expert review of vaccines·2015
    Same author

    Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
    Same author

    Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
    Same author

    Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013
    Same author

    Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013

    Area of Science:

    • Immunology
    • Parasitology
    • Cell Biology

    Background:

    • Trypanosoma cruzi is the causative agent of Chagas disease.
    • Macrophages play a critical role in the innate and adaptive immune response against T. cruzi.

    Purpose of the Study:

    • To investigate the role of immune macrophages and specific antibodies in the interaction with T. cruzi.
    • To evaluate the binding and destruction of T. cruzi epimastigotes and trypomastigotes by macrophages.

    Main Methods:

    • Peritoneal macrophages from normal and T. cruzi-immunized mice were used.
    • Macrophages were incubated with normal or immune sera and then infected with T. cruzi.
    • Specimens were analyzed using scanning electron microscopy after 2 hours of incubation.

    Related Experiment Videos

    Main Results:

    • Macrophages from immunized mice showed enhanced binding of both T. cruzi forms compared to normal macrophages.
    • Specific antibodies increased parasite binding to macrophages.
    • Extracellular destruction of both epimastigote and trypomastigote forms was observed.
    • Lysis of trypomastigotes required both immune macrophages and specific antibodies.

    Conclusions:

    • Immune macrophages and specific antibodies significantly enhance the interaction with T. cruzi.
    • The combination of immune macrophages and specific antibodies is essential for effective trypomastigote destruction.
    • This study highlights the importance of adaptive immunity in controlling T. cruzi infection.